Insider · CIK 0002014225
Rodney L Nussbaum
Files at GYRE (GYRE THERAPEUTICS, INC.). First filing -, latest -.
In brief
Rodney L Nussbaum files SEC Form 4 as director at GYRE (GYRE THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rodney L Nussbaum has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | GYRE GYRE THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 30, 2026 |
| Jun 4, 2025 | GYRE GYRE THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 6, 2025 |
Questions about Rodney L Nussbaum
Answered from the filings on this page, as of the latest one.
Is Rodney L Nussbaum buying or selling?
Rodney L Nussbaum has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rodney L Nussbaum's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rodney L Nussbaum has 0.
Where does Rodney L Nussbaum file Form 4?
Rodney L Nussbaum has filed Form 4 at GYRE (GYRE THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.